RC

Rajiv Chhelshankar Pandya

Active Director Director DIN 07271988
DIN 07271988 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Aug 2015
Shareholding value •••• Premium profile

About Rajiv Chhelshankar Pandya

Data last updated:

Rajiv Chhelshankar Pandya is a Director at Sidmak Laboratories (India) Private Limited (since 2024) and Director at Unimed Investments Limited (since 2024). The companies operate in Pharma, Real Estate and Construction and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹121 Cr; the largest is Sidmak Laboratories (India) Private Limited at ₹85.07 Cr (FY 2025). Earlier, Rajiv Chhelshankar Pandya was a Designated Partner at Dosti Seaview Realty Llp (2023–2025) and Designated Partner at Rayo Enterprises Llp (2020–2025) and 4 more.

DIN 07271988
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2015
Oldest Company Age 43 yrs
Largest company Sidmak Laboratories (India) Private Limited · ₹85.07 Cr (FY 2025)
Combined revenue ₹121 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Apr 20241983₹85.07 Cr (FY 2025)Active
Unimed Investments Limited U65999GJ1988PLC010304
Director09 Feb 20241988₹35.80 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Apr 20232010Active
Designated Partner10 Sep 20202020Active
Aditya Medisales Limited U24230GJ1990PLC014535
Cfo28 Aug 20151990₹7.48 Cr (FY 2025)Active
Designated Partner07 Apr 20222010Active
Mackinon Enterprises Private Limited U24230MH1996PTC101370
Director05 Apr 20221996₹505 Cr (FY 2025)Active
Asawari Property Private Limited U70100GJ1998PTC034188
Additional Director18 Jul 20161998₹1.08 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unimed Investments Limited
Sidmak Laboratories (India) Private Limited
Dosti Seaview Realty Llp
Rayo Enterprises Llp
Premium access

Shareholding and investment profile for Rajiv Chhelshankar Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Chhelshankar Pandya

Rajiv Chhelshankar Pandya currently holds 2 directorships: Sidmak Laboratories (India) Private Limited (Director, since 12 Apr 2024, revenue ₹85.07 Cr (FY 2025)); Unimed Investments Limited (Director, since 09 Feb 2024, revenue ₹35.80 Cr (FY 2025)).

Rajiv Chhelshankar Pandya was first appointed on 28 Aug 2015 as Cfo at Aditya Medisales Limited. The most recent appointment on record is 12 Apr 2024 at Sidmak Laboratories (India) Private Limited.

The 2 current companies of Rajiv Chhelshankar Pandya that report revenue have a combined latest revenue of ₹121 Cr: Sidmak Laboratories (India) Private Limited ₹85.07 Cr (FY 2025); Unimed Investments Limited ₹35.80 Cr (FY 2025).

Rajiv Chhelshankar Pandya held 6 earlier board appointments: Dosti Seaview Realty Llp (Designated Partner, 05 Apr 2023 to 06 May 2025); Rayo Enterprises Llp (Designated Partner, 10 Sep 2020 to 10 Apr 2025); Aditya Medisales Limited (Cfo, 28 Aug 2015 to 31 Mar 2025); Solar Power Technologies India Llp (Designated Partner, 07 Apr 2022 to 23 Mar 2025); Mackinon Enterprises Private Limited (Director, 05 Apr 2022 to 25 Mar 2025); and 1 more.

The current boards of Rajiv Chhelshankar Pandya's companies include Ashok Indulal Bhuta (Sidmak Laboratories (India) Private Limited), Dhananjay Thakorbhai Desai (Sidmak Laboratories (India) Private Limited), Raj Jaysingh Kariya (Sidmak Laboratories (India) Private Limited), Swati Chetan Jagetia (Sidmak Laboratories (India) Private Limited), Uday Ratilal Shah (Sidmak Laboratories (India) Private Limited), Vinayak Tulsidas Bhalani (Sidmak Laboratories (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available